2. Academic Validation
  3. Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)

Heterocyclic Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)

  • ACS Med Chem Lett. 2021 Oct 20;12(11):1641-1642. doi: 10.1021/acsmedchemlett.1c00532.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID: 34795852 DOI: 10.1021/acsmedchemlett.1c00532
Figures
Products